• Hastim
    • Mission and values
    • Immunotherapy and cancer
    • 5 year targets
    • Team
    • References & partnerships
    • Publications
    • Glossary
  • Animal Health
    • Cancer treatment
    • Diseases treated
    • Our results
    • Apavac® kit
    • Veterinarians
  • Human Health
    • Human oncology objective
    • Pre-clinical results
    • Toward clinical research
Password forgotten ?
Or Sign up
Contact Hastim
fr en
  • Hastim
    • Mission and values
    • Immunotherapy and cancer
    • 5 year targets
    • Team
    • References & partnerships
    • Publications
    • Glossary
  • Animal Health
    • Cancer treatment
    • Diseases treated
    • Our results
    • Apavac® kit
    • Veterinarians
  • Human Health
    • Human oncology objective
    • Pre-clinical results
    • Toward clinical research

References & partnerships

Partnerships and collaborations are essential to the development of Hastim in its permanent desire to exchange in R&D, production and regulations. They are facilitated and justified by the experience and profiles of the founding team with an academic background in chemistry and biology and developing for several years a constant link with the regional and national industrial health network.

    Home / References & partnerships

4 Mar 2021

France Relance

Among more than 1000 applications, in response to the national call for projects within the framework of France Relance (France’s recovery and resilience plan) to support investments and relocation in critical sectors, the company was selected in January 2021 among the 35 winners in the health sector.

Learn more
8 Apr 2021

Eurobiomed

In April 2021, the Strategic Project Council of the Eurobiomed cluster cited, as part of the call for expressions of interest “New biotherapies and production tools”, our phase I/II clinical study project in the context of diffuse large cell B lymphoma (LBDGC), for treatment in autologous immunotherapy.

Mail labelling
11 Jul 2022

INSERM U1231 | Equipe HSP-pathies

Involved for many years in international scientific research on the role of different heat shock proteins (HSP) in the mechanisms of differentiation and cell death and their involvement in anti-tumour immunogenicity, the team led by Ms Carmen GARRIDO, contracted a collaboration protocol with Hastim to explore and refine the influence of HSP in its innovative autologous immunotherapy process.

Learn more

28 Feb 2018

Sygnatures

Sygnatures has become Hastim’s global and sustainable contact for the advice and implementation of all our needs in the accounting, legal, tax and social fields, as well as payroll and human resources advice

Sygnatures
28 May 2016

Plasseraud

Plasseraud specialises in biotechnology innovation, its protection and all industrial property use operations. Plasseraud allows Hastim to best protect its brands and inventions and to exploit and/or have them exploited.

Plasseraud
28 Mar 2019

Euraudit

Relying on the stable and multidisciplinary team of Euraudit, we have been and will continue to be assisted during the different stages of the company’s life.

Euraudit

Contact Hastim for any questions

Message +33 (0)5 34 47 86 10
This content is dedicated to healthcare professionals

© Hastim 2022, Made by Novius